Nature Search

Erratum: CozE is a member of the MreCD complex that directs cell elongation in Streptococcus pneumoniae

Andrew K. Fenton
Lamya El Mortaji
Thomas G. Bernhardt
Amendments and Corrections23 Jan 2017
Nature Microbiology

Volume: 2, P: 1
Bacterial physiology: Wrapping the cell in a CozE shell

Recent work characterizing CozE, a protein that controls the function of the class A penicillin-binding protein PBP1a, sheds new light on our understanding of the synthesis of the bacterial peptidoglycan shell.

Adrien Ducret
Christophe Grangeasse
News & Views22 Feb 2017
Nature Microbiology

Volume: 2, P: 1-2
CozE is a member of the MreCD complex that directs cell elongation in Streptococcus pneumoniae

CozE is a member of the Streptoccocus pneumoniae MreCD complex that is required for PBP1a localization and activity during division.

Andrew K. Fenton
Lamya El Mortaji
Thomas G. Bernhardt
Research12 Dec 2016
Nature Microbiology

Volume: 2, P: 1-10
Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French Society of Pediatric Oncology

V Minard
O Hartmann
H Rubie
ResearchOpen Access19 Sept 2000
British Journal of Cancer

Volume: 83, P: 973-979
Low-dose interferon-γ-producing human neuroblastoma cells show reduced proliferation and delayed tumorigenicity

I Airoldi
R Meazza
M V Corrias
ResearchOpen Access04 May 2004
British Journal of Cancer

Volume: 90, P: 2210-2218
Lipoteichoic acid deficiency permits normal growth but impairs virulence of Streptococcus pneumoniae

Teichoic acid is bound to peptidoglycan (wall teichoic acid, WTA) or to membrane glycolipids (lipoteichoic acid, LTA) in most Gram-positive bacteria. Here, the authors identify a putative ligase required for the assembly of LTA, but not WTA, and important for Streptococcus pneumoniae virulence in mouse models.

Nathalie Heß
Franziska Waldow
Nicolas Gisch
ResearchOpen Access12 Dec 2017
Nature Communications

Volume: 8, P: 1-13
Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study

T Philip
R Ladenstein
P Biron
Research01 Jan 1993
British Journal of Cancer

Volume: 67, P: 119-127
Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide

H Rubie
J Michon
O Hartmann
Research01 Jun 1998
British Journal of Cancer

Volume: 77, P: 2310-2317
A decade of advances in transposon-insertion sequencing

In this Review, several experts discuss progress in the decade since the development of transposon-based approaches for bacterial genetic screens. They describe how advances in both experimental technologies and analytical strategies are resulting in insights into diverse biological processes.

Amy K. Cain
Lars Barquist
Tim van Opijnen
Reviews12 Jun 2020
Nature Reviews Genetics

Volume: 21, P: 526-540
The LMCE5 unselected cohort of 25 children consecutively diagnosed with untreated stage 4 neuroblastoma over 1 year at diagnosis

D Frappaz
D Perol
T Philip
ResearchOpen Access12 Nov 2002
British Journal of Cancer

Volume: 87, P: 1197-1203
Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation

V Combaret
MC Favrot
T Philip
Research01 Jun 1989
British Journal of Cancer

Volume: 59, P: 844-847
Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol

A Atra
J D Imeson
C R Pinkerton
ResearchOpen Access21 Mar 2000
British Journal of Cancer

Volume: 82, P: 1396-1402
Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression

V Combaret
N Gross
J-L Coll
Research01 Apr 1997
British Journal of Cancer

Volume: 75, P: 1151-1155
Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies

C-H Pui
MV Relling
HH Mahmoud
Research01 Nov 1997
Leukemia

Volume: 11, P: 1813-1816
High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study

C Chabannon
K Cornetta
P Viens
Research01 Oct 1998
British Journal of Cancer

Volume: 78, P: 913-921
BCL6 rearrangement and mediastinal involvement in a case of B cell acute lymphoblastic leukemia

JE Rubnitz
B Abushullaih
FG Behm
Correspondence24 Jul 1998
Leukemia

Volume: 12, P: 1163-1165
Fluorescence in situ hybridization techniques for the rapid detection of genetic prognostic factors in neuroblastoma

C P F Taylor
N P Bown
Denise Sheer
ResearchOpen Access06 Jun 2000
British Journal of Cancer

Volume: 83, P: 40-49
Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations

I Boland
G Vassal
A Gouyette
ResearchOpen Access29 Jan 1999
British Journal of Cancer

Volume: 79, P: 787-792
Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study)

O Oberlin
M C Le Deley
J Michon
ResearchOpen Access27 Nov 2001
British Journal of Cancer

Volume: 85, P: 1646-1654
Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement

Beckwith–Wiedemann syndrome is an overgrowth disorder characterized by variable clinical phenotypes and a complex molecular aetiology. This Consensus Statement summarizes recommendations for clinical indications, molecular diagnosis and management of the newly defined Beckwith–Wiedemann spectrum.

Frédéric Brioude
Jennifer M. Kalish
Eamonn R. Maher
ReviewsOpen Access29 Jan 2018
Nature Reviews Endocrinology

Volume: 14, P: 229-249
Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy

H Rubie
C Coze
O Hartmann
ResearchOpen Access28 Oct 2003
British Journal of Cancer

Volume: 89, P: 1605-1609
Cost effectiveness of day 5 G-CSF (Lenograstim^®) administration after PBSC transplantation: results of a SFGM-TC randomised trial

D Valteau-Couanet
C Faucher
E Benhamou
Research11 Jul 2005
Bone Marrow Transplantation

Volume: 36, P: 547-552
Hematopoietic stem cell transplantation for hematological malignancies in Europe

A Gratwohl
H Baldomero
A Urbano-Ispizua
Research15 May 2003
Leukemia

Volume: 17, P: 941-959
Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation

M Miano
M Labopin
G Dini
Research10 Jan 2007
Bone Marrow Transplantation

Volume: 39, P: 89-99
Treatment of stage 4s neuroblastoma – report of 10 years' experience of the French Society of Paediatric Oncology (SFOP)

G Schleiermacher
H Rubie
J Michon
ResearchOpen Access29 Jul 2003
British Journal of Cancer

Volume: 89, P: 470-476
The EBMT activity survey: 1990–2010

J R Passweg
H Baldomero
A Madrigal
Special Features30 Apr 2012
Bone Marrow Transplantation

Volume: 47, P: 906-923
EBMT activity survey 2004 and changes in disease indication over the past 15 years

A Gratwohl
H Baldomero
A Urbano-Ispizua
Special Features07 Jun 2006
Bone Marrow Transplantation

Volume: 37, P: 1069-1085
Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey

A Gratwohl
H Baldomero
A Urbano-Ispizua
Special Features12 Dec 2002
Bone Marrow Transplantation

Volume: 30, P: 813-831
Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors

A Gratwohl
H Baldomero
D Niederwieser
Special Features10 Jan 2007
Bone Marrow Transplantation

Volume: 39, P: 71-87
Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003

A Gratwohl
H Baldomero
A Urbano-Ispizua
Special Features08 Aug 2005
Bone Marrow Transplantation

Volume: 36, P: 575-590
Hematopoietic stem cell transplantation activity in Europe 1999

A Gratwohl
J Passweg
A Urbano-Ispizua
Special Features02 Jul 2001
Bone Marrow Transplantation

Volume: 27, P: 899-916
Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey

A Gratwohl
O Schmid
A Urbano-Ispizua
Special Features02 Nov 2004
Bone Marrow Transplantation

Volume: 34, P: 855-875
Outcome of 5651 hematopoietic stem cell transplants for hematological malignancies carried out in Europe in 1993: a reliability study of the registry

L Fouillard
M Labopin
NC Gorin
Special Features06 Nov 2002
Bone Marrow Transplantation

Volume: 30, P: 637-643
Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time

A Gratwohl
R Brand
C Cordonnier
Special Features05 Sept 2005
Bone Marrow Transplantation

Volume: 36, P: 757-769

Search

Erratum: CozE is a member of the MreCD complex that directs cell elongation in Streptococcus pneumoniae

Bacterial physiology: Wrapping the cell in a CozE shell

CozE is a member of the MreCD complex that directs cell elongation in Streptococcus pneumoniae

Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French Society of Pediatric Oncology

Low-dose interferon-γ-producing human neuroblastoma cells show reduced proliferation and delayed tumorigenicity

Lipoteichoic acid deficiency permits normal growth but impairs virulence of Streptococcus pneumoniae

Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study

Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide

A decade of advances in transposon-insertion sequencing

The LMCE5 unselected cohort of 25 children consecutively diagnosed with untreated stage 4 neuroblastoma over 1 year at diagnosis

Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation

Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol

Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression

Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies

High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study

BCL6 rearrangement and mediastinal involvement in a case of B cell acute lymphoblastic leukemia

Fluorescence in situ hybridization techniques for the rapid detection of genetic prognostic factors in neuroblastoma

Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations

Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study)

Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement

Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy

Cost effectiveness of day 5 G-CSF (Lenograstim^®) administration after PBSC transplantation: results of a SFGM-TC randomised trial

Hematopoietic stem cell transplantation for hematological malignancies in Europe

Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation

Treatment of stage 4s neuroblastoma – report of 10 years' experience of the French Society of Paediatric Oncology (SFOP)

The EBMT activity survey: 1990–2010

EBMT activity survey 2004 and changes in disease indication over the past 15 years

Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey

Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors

Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003

Hematopoietic stem cell transplantation activity in Europe 1999

Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey

Outcome of 5651 hematopoietic stem cell transplants for hematological malignancies carried out in Europe in 1993: a reliability study of the registry

Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time

Search

Quick links

Search

Filter By:

Search

Quick links